GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a rheumatic disease. Growth differentiation factor 15 (GDF-15) is a member of transforming growth factor-β superfamily. To date, association of GDF-15 with SLE pathogenesis is not clarified. This study discussed GDF-15 serum levels and gene polymorphisms in SLE...
Main Authors: | Wang-Dong Xu, Qi Huang, Chan Yang, Rong Li, An-Fang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.926373/full |
Similar Items
-
Metabolic syndrome in patients with systemic lupus erythematosus
by: T Y Popkova, et al.
Published: (2008-08-01) -
Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
by: Everton Carlos Siviero do Vale, et al.
Published: (2023-06-01) -
FOXP3 Gene Variants in Patients with Systemic Lupus Erythematosus: Association with Disease Susceptibility in Men and Relationship with Abortion in Women
by: Paria Heydarinezhad, et al.
Published: (2022-06-01) -
Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
by: Julianne Kleitsch, BA, et al.
Published: (2023-11-01) -
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
by: Mutali Musa, et al.
Published: (2024-02-01)